Robert E. Landry
2018
Compensation breakdown
Non-Equity Incentive Plan | $581,400 |
---|---|
Option Awards | $3,308,184 |
Salary | $680,000 |
Stock Awards | $4,767,500 |
Other | $19,535 |
Total | $9,356,619 |
Landry received $4.8M in stock awards, accounting for 51% of the total pay in 2018.
Landry also received $581.4K in non-equity incentive plan, $3.3M in option awards, $680K in salary and $19.5K in other compensation.
Rankings
In 2018, Robert E. Landry's compensation ranked 772nd out of 14,244 executives tracked by ExecPay. In other words, Landry earned more than 94.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 772 out of 14,244 | 95th |
Division Manufacturing | 254 out of 5,765 | 96th |
Major group Chemicals And Allied Products | 74 out of 2,128 | 97th |
Industry group Drugs | 57 out of 1,817 | 97th |
Industry Pharmaceutical Preparations | 39 out of 1,391 | 97th |
Landry's colleagues
We found four more compensation records of executives who worked with Robert E. Landry at Regeneron Pharmaceuticals in 2018.
2018
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2018
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
2018
Marion McCourt
Regeneron Pharmaceuticals
Senior Vice President, Commercial
2018
Daniel Van Plew
Regeneron Pharmaceuticals
Executive Vice President and General Manager, Industrial Operations and Product Supply
News
April 21, 2022
April 23, 2021
April 24, 2020
April 26, 2019